Virtu Financial LLC reduced its holdings in China Cord Blood Corp (NYSE:CO) by 53.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 33,356 shares of the medical research company’s stock after selling 37,566 shares during the quarter. Virtu Financial LLC’s holdings in China Cord Blood were worth $332,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of CO. Ameriprise Financial Inc. acquired a new stake in China Cord Blood in the third quarter valued at approximately $3,881,000. Nationwide Fund Advisors acquired a new stake in China Cord Blood in the third quarter valued at approximately $372,000. California Public Employees Retirement System grew its stake in China Cord Blood by 32.6% in the third quarter. California Public Employees Retirement System now owns 182,609 shares of the medical research company’s stock valued at $2,031,000 after acquiring an additional 44,909 shares during the period. Wells Fargo & Company MN grew its stake in China Cord Blood by 1,260,105.6% in the third quarter. Wells Fargo & Company MN now owns 226,837 shares of the medical research company’s stock valued at $2,522,000 after acquiring an additional 226,819 shares during the period. Finally, PEAK6 Investments L.P. grew its stake in China Cord Blood by 8.4% in the third quarter. PEAK6 Investments L.P. now owns 175,657 shares of the medical research company’s stock valued at $1,953,000 after acquiring an additional 13,657 shares during the period. Institutional investors and hedge funds own 21.95% of the company’s stock.
Shares of China Cord Blood Corp (NYSE:CO) opened at $10.88 on Tuesday. China Cord Blood Corp has a one year low of $5.06 and a one year high of $14.95. The company has a market capitalization of $1,288.06, a P/E ratio of 31.41 and a beta of 0.88.
ILLEGAL ACTIVITY WARNING: This article was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/03/13/china-cord-blood-corp-co-shares-sold-by-virtu-financial-llc.html.
China Cord Blood Company Profile
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.
Want to see what other hedge funds are holding CO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for China Cord Blood Corp (NYSE:CO).
Receive News & Ratings for China Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.